News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
679,423 Results
Type
Article (55804)
Company Profile (401)
Press Release (623218)
Section
Business (183842)
Career Advice (3251)
Deals (32778)
Drug Delivery (121)
Drug Development (82588)
Employer Resources (178)
FDA (16180)
Job Trends (14496)
News (322887)
Policy (32129)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (9)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2915)
Academic (1)
Accelerated approval (3)
Adcomms (29)
Allergies (81)
Alliances (46765)
ALS (83)
Alzheimer's disease (1427)
Antibody-drug conjugate (ADC) (125)
Approvals (16136)
Artificial intelligence (231)
Autoimmune disease (13)
Automation (13)
Bankruptcy (327)
Best Places to Work (11761)
BIOSECURE Act (19)
Biosimilars (100)
Biotechnology (308)
Bladder cancer (57)
Brain cancer (26)
Breast cancer (245)
Cancer (1899)
Cardiovascular disease (153)
Career advice (2734)
Career pathing (31)
CAR-T (149)
Cell therapy (423)
Cervical cancer (15)
Clinical research (66138)
Collaboration (742)
Compensation (377)
Complete response letters (29)
COVID-19 (2779)
CRISPR (38)
C-suite (189)
Cystic fibrosis (104)
Data (1737)
Decentralized trials (2)
Denatured (30)
Depression (45)
Diabetes (238)
Diagnostics (6274)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (46)
Drug discovery (111)
Drug pricing (115)
Drug shortages (31)
Duchenne muscular dystrophy (68)
Earnings (70627)
Editorial (34)
Employer branding (22)
Employer resources (156)
Events (111530)
Executive appointments (599)
FDA (17174)
Featured Employer (61)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (660)
Gene editing (95)
Generative AI (24)
Gene therapy (299)
GLP-1 (764)
Government (4907)
Grass and pollen (4)
Guidances (43)
Healthcare (19763)
Huntington's disease (24)
IgA nephropathy (23)
Immunology and inflammation (103)
Indications (24)
Infectious disease (2907)
Inflammatory bowel disease (138)
Inflation Reduction Act (11)
Influenza (45)
Intellectual property (71)
Interviews (631)
IPO (15670)
IRA (47)
Job creations (3200)
Job search strategy (2250)
Kidney cancer (10)
Labor market (25)
Layoffs (494)
Leadership (18)
Legal (7080)
Liver cancer (73)
Lung cancer (278)
Lymphoma (122)
Machine learning (2)
Management (61)
Manufacturing (267)
MASH (62)
Medical device (13061)
Medtech (13064)
Mergers & acquisitions (17534)
Metabolic disorders (647)
Multiple sclerosis (64)
NASH (23)
Neurodegenerative disease (86)
Neuropsychiatric disorders (29)
Neuroscience (1904)
NextGen: Class of 2025 (6959)
Non-profit (4846)
Northern California (2199)
Now hiring (34)
Obesity (359)
Opinion (258)
Ovarian cancer (63)
Pain (80)
Pancreatic cancer (69)
Parkinson's disease (124)
Partnered (17)
Patents (188)
Patient recruitment (82)
Peanut (49)
People (54198)
Pharmaceutical (80)
Pharmacy benefit managers (21)
Phase I (20637)
Phase II (29148)
Phase III (21850)
Pipeline (826)
Podcasts (95)
Policy (117)
Postmarket research (2582)
Preclinical (8873)
Press Release (67)
Prostate cancer (89)
Psychedelics (38)
Radiopharmaceuticals (263)
Rare diseases (373)
Real estate (5521)
Recruiting (70)
Regulatory (22085)
Reports (35)
Research institute (2554)
Resumes & cover letters (518)
Rett syndrome (2)
RNA editing (1)
RSV (43)
Schizophrenia (69)
Series A (121)
Series B (71)
Service/supplier (10)
Sickle cell disease (55)
Southern California (1888)
Special edition (17)
Sponsored (32)
Startups (3522)
State (2)
Stomach cancer (14)
Supply chain (59)
The Weekly (64)
United States (19556)
Vaccines (711)
Venture capitalists (35)
Webinars (13)
Weight loss (267)
Women's health (31)
Worklife (16)
Date
Today (190)
Last 7 days (842)
Last 30 days (3005)
Last 365 days (35458)
2025 (5767)
2024 (36280)
2023 (40777)
2022 (51714)
2021 (56272)
2020 (54815)
2019 (48189)
2018 (36563)
2017 (33471)
2016 (32944)
2015 (38039)
2014 (29963)
2013 (24998)
2012 (26604)
2011 (27059)
2010 (24563)
Location
Africa (923)
Alabama (53)
Alaska (7)
Arizona (161)
Arkansas (13)
Asia (39761)
Australia (6976)
California (5048)
Canada (1763)
China (435)
Colorado (226)
Connecticut (241)
Delaware (111)
Europe (92094)
Florida (738)
Georgia (173)
Idaho (59)
Illinois (496)
India (21)
Indiana (261)
Iowa (8)
Japan (126)
Kansas (101)
Kentucky (24)
Louisiana (8)
Maine (65)
Maryland (796)
Massachusetts (3943)
Michigan (205)
Minnesota (345)
Mississippi (1)
Missouri (69)
Montana (27)
Nebraska (25)
Nevada (46)
New Hampshire (61)
New Jersey (1424)
New Mexico (29)
New York (1436)
North Carolina (926)
North Dakota (8)
Northern California (2199)
Ohio (174)
Oklahoma (13)
Oregon (32)
Pennsylvania (1122)
Puerto Rico (5)
Rhode Island (23)
South America (1246)
South Carolina (14)
South Dakota (1)
Southern California (1888)
Tennessee (79)
Texas (726)
Utah (147)
Virginia (122)
Washington D.C. (56)
Washington State (494)
West Virginia (3)
Wisconsin (42)
679,423 Results for "the als association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The ALS Association Announces 2025 ‘ALS Nexus’ Conference
January 17, 2025
·
3 min read
Press Releases
New ALS Association-Led Research Finds Specialists Diagnose ALS Twice as Fast as General Neurologists
December 11, 2024
·
4 min read
Pharm Country
ProJenX Announces Receipt of $1M Hoffman ALS Clinical Trial Award from the ALS Association
ProJenX, Inc. announced the receipt of a $1M Hoffman ALS Clinical Trials Award from the ALS Association.
June 20, 2024
·
4 min read
Press Releases
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND
December 9, 2024
·
5 min read
Regulatory
FDA Presses Pause on Atara’s Programs, Play on Amylyx’s ALS Assets
The FDA is putting Atara’s active Investigational New Drug applications on hold due to manufacturing concerns at a third-party provider while releasing Amylyx’s investigational ALS therapy from a previous pause.
January 22, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
November 19, 2024
·
6 min read
BioCapital
The ALS Association Announces Inaugural ‘ALS Nexus’ Conference
The ALS Association, the leading national non-profit organization dedicated to fighting ALS on every front, is excited to announce its inaugural ALS Nexus Conference, taking place July 14-17, 2024 at The Gaylord Texan Resort & Conference Center in Grapevine, Texas.
March 22, 2024
·
3 min read
ALS
HEALEY ALS Trial Serves Up More Disappointment as Denali, AbbVie/Calico Fail
Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the latest setbacks for the controversial platform trial, the results from which have largely mirrored the dismal success rate in ALS overall.
January 10, 2025
·
5 min read
·
Heather McKenzie
Press Releases
Adeno-associated Virus Gene Therapy Market Size to Reach USD 107.2 Billion by 2035, Impelled by Advancements in Personalized Medicine.
Adeno-associated Virus Gene Therapy Market Outlook 2025-2035:
February 17, 2025
·
11 min read
Press Releases
Voyager Provides Update on SOD1 ALS Gene Therapy Program
February 11, 2025
·
6 min read
1 of 67,943
Next
